Glucocorticoids delivered by inorganic-organic hybrid nanoparticles mitigate acute graft-versus-host disease and sustain graft-versus-leukemia activity.
This article is protected by copyright. All rights reserved.
PMID: 32133644 [PubMed - as supplied by publisher]
Source: European Journal of Immunology - Category: Allergy & Immunology Authors: Kaiser TK, Li H, Roßmann L, Reichardt SD, Bohnenberger H, Feldmann C, Reichardt HM Tags: Eur J Immunol Source Type: research
More News: Acute Leukemia | Allergy & Immunology | Genetics | Leukemia | Lymphoma | Nanotechnology | Organic